T-Bird Pharma announces closing of transaction with Medna Biosciences
T-Bird Pharma announced it has closed the transaction announced March 11 with Medna Biosciences, which acquired a total of 20,156,790 common shares of T-Bird (45% of the Company's issued shares) from five of its founding shareholders, including its former CEO and CFO, at a price of $0.21 per share. April 24, 2015